Price T Rowe Associates Inc Anika Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$21.74 - $24.68 $195,616 - $222,070	8,998 New	8,998 $215,000
Q1 2022 May 16, 2022	SELL	$24.7 - $36.54 $189,177 - $279,859	-7,659 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.83 - $45.03 $15,586 - $19,588	435 Added 6.02%	7,659 $274,000
Q3 2021 Nov 15, 2021	BUY	$38.75 - $44.47 $1,046 - $1,200	27 Added 0.38%	7,224 $307,000
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $27,909 - $34,040	708 Added 10.91%	7,197 $312,000
Q1 2021 May 17, 2021	SELL	$32.49 - $45.96 $552 - $781	-17 Reduced 0.26%	6,489 $265,000
Q4 2020 Feb 16, 2021	BUY	$32.59 - $45.26 $212,030 - $294,461	6,506 New	6,506 $294,000

118

11.8M

2.7K

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $358M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.